Literature DB >> 2903699

Microtubule-granule relationships in motile human polymorphonuclear leukocytes.

M I Ryder1, R N Weinreb, R Niederman.   

Abstract

We examined the relationship of microtubules to the granule organization in stimulated human polymorphonuclear leukocytes (PMNs). Electron microscopic (EM) observations of critical-point-dried PMNs revealed that only a portion of the granules appeared in close association to microtubules. These closely associated granules appeared to be attached to the microtubule via smaller-diameter filaments. The remaining granules appeared either attached to microtubules at a further distance, via smaller-diameter filaments such as actin, or unassociated with microtubules. EM observations of PMNs treated with either the microtubule promoter drug taxol or the microtubule depolymerization drugs nocodozole and colchicine revealed a redistribution of granules towards the nucleus. Granule clustering at the periphery of the cell was also noted with nocodozole and colchicine. With cytochalasin B, a uniform distribution of granules was noted. However, granule clustering was noted when PMNs were coincubated with cytochalasin B and colchicine. These results indicate that microtubules may have both a direct and indirect role (through other cytoskeletal elements) in the organization of PMN granules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903699     DOI: 10.1002/ar.1092210302

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  2 in total

1.  Chemotactic peptide-induced changes of intermediate filament organization in neutrophils during granule secretion: role of cyclic guanosine monophosphate.

Authors:  K B Pryzwansky; E P Merricks
Journal:  Mol Biol Cell       Date:  1998-10       Impact factor: 4.138

2.  Chemoattractant-induced NADPH oxidase activity in human monocytes is terminated without any association of receptor-ligand complex to cytoskeleton.

Authors:  A Johansson; E Särndahl; T Andersson; T Bengtsson; H Lundqvist; C Dahlgren
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.